
|Articles|December 27, 2017
Supplements and Featured Publications
- Dermatology Compendium
Dermatology Compendium
Advertisement
In This Issue:
- Atopic Dermatitis: Burden, Pathogenesis, and Treatment
- Review Finds Topical Corticosteroid Phobia in Atopic Dermatitis Contributes to Medication Nonadherence
- Dermira Obtains Exclusive Rights
- for Commercialization of Atopic Dermatitis Drug
- Immune-Cell Numbers Determine Combination Immunotherapy Response in Melanoma Patients
- Psoriasis Linked to High Cholesterol Levels, Study Finds
- Telehealth for Melanoma? Dermatologists Prove It Is Possible
- Guselkumab Gains FDA Approval for Plaque Psoriasis
- No Evidence Found of Plaque Psoriasis Medications Triggering IBD
- Comorbidities Associated With Psoriasis Create Burden Among Patients
- Probiotics Do Not Have a Significant Impact on Preventing Eczema, Asthma in Infants
- Above-Label Doses for Treating Psoriasis Can Lead to Higher Annual Treatment Costs
- Study Finds Strongest Link Yet Between Tanning Beds and Cancer, Especially Among Teens
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
3
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
4
Biktarvy Improves ART Persistence for People With HIV and Mental Health Disorders
5















































